Shares of Affymetrix dropped 14.2 percent for the five-day trading period ended Tuesday. The firm’s shares fell 9.6 percent on Tuesday alone after it said it had filed a shelf registration to offer $250 million of senior convertible notes (see Briefs).
 
Canaccord Adams analyst Matthew Scalo speculated in an interview with Reuters that Affymetrix may be looking for a “sizeable acquisition.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.